-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
MoonLake Immunotherapeutics quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2021 to Q3 2024.
- MoonLake Immunotherapeutics Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $92.1K, a 218% increase year-over-year.
- MoonLake Immunotherapeutics Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $285K, a 367% increase year-over-year.
- MoonLake Immunotherapeutics annual Income Tax Expense (Benefit) for 2023 was $94.4K, a 160% increase from 2022.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)